Simplex Trading
FCSC

Simplex Trading’s Fibrocell Science Inc. FCSC Stock Holding History

Simplex Trading’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-11
Closed -$18K – 6627
2015
Q4 		$18K Buy
11
+6
+120% +$431 ﹤0.01% 2804
2015
Q3 		$13K Buy
+5
New +$443 ﹤0.01% 3232

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's FCSC Position: Q1 2018 in Review

Simplex Trading sold out of Fibrocell Science Inc. (FCSC) in Q1 2018, closing a stake of 24 shares.

Simplex Trading first reported a position in FCSC in Q1 2015 and held it in 5 quarters. The position peaked at $36K in Q4 2015. 30 funds tracked by Wall St. Rank hold FCSC as of Q1 2018.

  • Simplex Trading reported no remaining Fibrocell Science Inc. position as of Q1 2018 after selling out during the quarter.
  • Simplex Trading sold 24 Fibrocell Science Inc. shares in Q1 2018.
  • Simplex Trading first reported a position in Fibrocell Science Inc. in Q1 2015 and held it in 5 quarters.
  • Simplex Trading's Fibrocell Science Inc. position peaked at $36K in Q4 2015.
  • 30 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q1 2018.

Based on Simplex Trading's 13F filing for Q1 2018, filed 26 Apr 2018.